Navidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated at StockNews.com
Stock analysts at StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a report released on Saturday. The brokerage set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Performance NYSE:NAVB opened at $0.00 on Friday. Navidea Biopharmaceuticals has a twelve month low of $0.00 and a twelve month high […]
Stock analysts at StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a report released on Saturday. The brokerage set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Performance NYSE:NAVB opened at $0.00 on Friday. Navidea Biopharmaceuticals has a twelve month low of $0.00 and a twelve month high […]
